SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-15 |
| Reported value | $164,207,527 |
| Positions | 51 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| PRAXIS PRECISION MEDICINES I | PRAX | COM NEW | $29,722,991 | 88,781 |
| MAPLIGHT THERAPEUTICS INC | MPLT | COM | $17,665,285 | 492,893 |
| SUTRO BIOPHARMA INC | STRO | COM SHS | $17,003,712 | 512,160 |
| IMMIX BIOPHARMA INC | IMMX | COM | $11,186,350 | 1,085,000 |
| PROTARA THERAPEUTICS INC | TARA | COM STK | $10,866,571 | 2,844,652 |
| ABIVAX SA | ABVX | SPONSORED ADS | $8,745,854 | 65,630 |
| TENAX THERAPEUTICS INC | TENX | COM NEW | $8,002,282 | 549,985 |
| ANTERIS TECHNOLOGIES GLOBAL | AVR | COM | $6,895,000 | 700,000 |
| EDESA BIOTECH INC | EDSA | COM NEW | $6,727,575 | 827,500 |
| EVOMMUNE INC | EVMN | COM SHS | $5,997,179 | 451,255 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.